Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter revision text updated from Revision: v3.2.0 to Revision: v3.3.2; overall page content and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page removed a generic government funding status notice; this is a non-critical change that does not affect the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check38 days agoChange DetectedResults and outcome data have been added, including safety and efficacy measures such as TEAEs/SAEs, surgical outcomes, and survival.SummaryDifference0.4%

- Check60 days agoChange DetectedCore content now includes an important government-operating-status notice and the site version is updated to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check67 days agoChange DetectedUpdate indicates a new software/version release (v3.1.0) replacing the previous version (v3.0.2).SummaryDifference0.1%

- Check81 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.